Literature DB >> 20709256

Uptake of regular chlamydia testing by U.S. women: a longitudinal study.

Janneke C M Heijne1, Guoyu Tao, Charlotte K Kent, Nicola Low.   

Abstract

BACKGROUND: Routine chlamydia screening is a recommended preventive intervention for sexually active women aged </=25 years in the U.S. but rates of regular uptake are not known.
PURPOSE: This study aimed to examine rates of annual chlamydia testing and factors associated with repeat testing in a population of U.S. women.
METHODS: Women aged 15-25 years at any time from January 1, 2002, to December 31, 2006 who were enrolled in 130 commercial health plans were included. Data relating to chlamydia tests were analyzed in 2009. Chlamydia testing rates (per 100 woman-years) by age and rates of repeated annual testing were estimated. Poisson regression was used to examine the effects of age and previous testing on further chlamydia testing within the observation period.
RESULTS: In total, 2,632,365 women were included. The chlamydia testing rate over the whole study period was 13.6 per 100 woman years after adjusting for age-specific sexual activity; 8.5 (95% CI=6.0, 12.3) per 100 woman-years in those aged 15 years; and 17.7 (95% CI=17.1, 18.9) in those aged 25 years. Among women enrolled for the entire 5-year study period, 25.9% had at least one test but only 0.1% had a chlamydia test every year. Women tested more than once and older women were more likely to be tested again in the observation period.
CONCLUSIONS: The low rates of regular annual chlamydia testing do not comply with national recommendations and would not be expected to have a major impact on the control of chlamydia infection at the population level. 2010 American Journal of Preventive Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20709256     DOI: 10.1016/j.amepre.2010.05.011

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  16 in total

1.  Temporal Patterns in Chlamydia Repeat Testing in Massachusetts.

Authors:  Elizabeth C Dee; Katherine K Hsu; Benjamin A Kruskal; John T Menchaca; Bob Zambarano; Noelle Cocoros; Brian Herrick; Michelle D Payne Weiss; Ellen Hafer; Diana Erani; Mark Josephson; Jessica Young; Elizabeth A Torrone; Elaine W Flagg; Michael Klompas
Journal:  Am J Prev Med       Date:  2019-03       Impact factor: 5.043

2.  Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.

Authors:  Christine M Khosropour; Jennifer M Broad; Delia Scholes; Jacquelyn Saint-Johnson; Lisa E Manhart; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2014-11       Impact factor: 2.830

3.  Screening for asymptomatic urogenital Chlamydia trachomatis infection at a large Dublin maternity hospital: results of a pilot study.

Authors:  A C O'Higgins; V Jackson; M Lawless; D Le Blanc; G Connolly; R Drew; M Eogan; J S Lambert
Journal:  Ir J Med Sci       Date:  2016-03-11       Impact factor: 1.568

4.  Factors associated with screening for sexually transmitted infections.

Authors:  Stephanie L Skala; Gina M Secura; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2012-02-28       Impact factor: 8.661

5.  Sustained Reduction in Chlamydia Infections Following a School-Based Screening: Detroit, 2010-2015.

Authors:  Richard Dunville; Amy Peterson; Nicole Liddon; Mary Roach; Kenneth Coleman; Patricia Dittus
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

6.  Reproductive health preventive screening among clinic vs. over-the-counter oral contraceptive users.

Authors:  Kristine Hopkins; Daniel Grossman; Kari White; Jon Amastae; Joseph E Potter
Journal:  Contraception       Date:  2012-04-20       Impact factor: 3.375

7.  Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

Authors:  Ingrid V F van den Broek; Jan E A M van Bergen; Elfi E H G Brouwers; Johannes S A Fennema; Hannelore M Götz; Christian J P A Hoebe; Rik H Koekenbier; Mirjam Kretzschmar; Eelco A B Over; Boris V Schmid; Lydia L Pars; Sander M van Ravesteijn; Marianne A B van der Sande; G Ardine de Wit; Nicola Low; Eline L M Op de Coul
Journal:  BMJ       Date:  2012-07-05

8.  The Influence of Screening, Misclassification, and Reporting Biases on Reported Chlamydia Case Rates Among Young Women in the United States, 2000 Through 2017.

Authors:  Emily R Learner; Kimberly A Powers; Elizabeth A Torrone; Brian W Pence; Jason P Fine; William C Miller
Journal:  Sex Transm Dis       Date:  2020-06       Impact factor: 2.830

9.  Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.

Authors:  Sami L Gottlieb; Nicola Low; Lori M Newman; Gail Bolan; Mary Kamb; Nathalie Broutet
Journal:  Vaccine       Date:  2014-02-25       Impact factor: 3.641

10.  Sexually transmitted infection laboratory testing and education trends in US outpatient physician offices, 2009-2016.

Authors:  Amina R Zeidan; Kelsey Strey; Michelle N Vargas; Kelly R Reveles
Journal:  Fam Med Community Health       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.